Announce Date | 07/30/2025 |
EPS Normalized Actual | $1.97 (Beat by $0.28) |
EPS GAAP Actual | $1.97 (Beat by $0.28) |
Revenue Actual | $2.8625B |
Revenue Surprise | Beat by $2862.5M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 3.06569 | 53.62 | 2.75272 | 3.46813 | 2 |
Dec 2028 | 2.49436 | 65.9 | 2.33693 | 2.67193 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 2.16 | 2.16 | 2.8625B | 27.47% | 2862.5M |
FQ1 2025 (Mar 2025) | 1.62 | 1.62 | 2.46825B | 26.2% | 2468.25M |
FQ4 2024 (Oct 2024) | 1.13 | 1.13 | 2.15561B | 16.26% | 2155.61M |
FQ2 2024 (Jun 2024) | 0.94 | 0.94 | 2.07619B | 17.24% | 2076.19M |
FQ1 2024 (Mar 2024) | 0.69 | 0.69 | 1.82165B | 17.13% | 1821.65M |
FQ4 2023 (Dec 2023) | -0.79 | -0.79 | 1.80519B | 23.29% | 1805.19M |
FQ3 2023 (Sep 2023) | 0.36 | 0.36 | 1.64241B | 11.73% | 1642.41M |
FQ2 2023 (Jun 2023) | 0.66 | 0.66 | 1.7182B | 100% | 1718.2M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2029 (Jan 2029) | 1.03434 | -- | 0.98893 | 1.07152 | 1 |
FQ4 2028 (Oct 2028) | 1.03394 | -- | 0.98854 | 1.07111 | 1 |
FQ3 2028 (Jul 2028) | 1.02906 | -- | 0.98388 | 1.06605 | 1 |
FQ2 2028 (Apr 2028) | 0.87984 | -- | 0.84121 | 0.91147 | 1 |
FQ1 2028 (Jan 2028) | 0.94796 | -- | 0.92304 | 0.97172 | 1 |
FQ4 2027 (Oct 2027) | 0.93049 | -- | 0.90603 | 0.95382 | 1 |
FQ3 2027 (Jul 2027) | 0.90173 | -- | 0.87803 | 0.92434 | 1 |
FQ2 2027 (Apr 2027) | 0.87098 | -- | 0.84809 | 0.89281 | 1 |
FQ1 2027 (Mar 2027) | 0.56315 | -- | 0.54723 | 0.58094 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2029 (Jan 2029) | 6.27B | -- | 6.05B | 6.44B | 1 |
FQ4 2028 (Oct 2028) | 5.89B | -- | 5.69B | 6.05B | 1 |
FQ3 2028 (Jul 2028) | 5.53B | -- | 5.35B | 5.69B | 1 |
FQ2 2028 (Apr 2028) | 5.2B | -- | 5.02B | 5.34B | 1 |
FQ1 2028 (Jan 2028) | 1.68B | -- | 1.65B | 1.72B | 1 |
FQ4 2027 (Oct 2027) | 1.68B | -- | 1.65B | 1.72B | 1 |
FQ3 2027 (Jul 2027) | 1.68B | -- | 1.65B | 1.72B | 1 |
FQ2 2027 (Apr 2027) | 1.82B | -- | 1.78B | 1.85B | 1 |
FQ1 2027 (Mar 2027) | 7.67B | -- | 7.51B | 7.86B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 2.16 | 2.16 | 100% | |
FQ1 2025 (Mar 2025) | 1.62 | 1.62 | 100% | |
FQ4 2024 (Oct 2024) | 1.13 | 1.13 | 100% | |
FQ2 2024 (Jun 2024) | 0.94 | 0.94 | 100% | |
FQ1 2024 (Mar 2024) | 0.69 | 0.69 | 100% | |
FQ4 2023 (Dec 2023) | -0.79 | -0.79 | 100% | |
FQ3 2023 (Sep 2023) | 0.36 | 0.36 | 100% | |
FQ2 2023 (Jun 2023) | 0.66 | 0.66 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0B | $2.86B | $2862.5M | 100% |
FQ1 2025 (Mar 2025) | $0B | $2.47B | $2468.25M | 100% |
FQ4 2024 (Oct 2024) | $0B | $2.16B | $2155.61M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.08B | $2076.19M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.82B | $1821.65M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.81B | $1805.19M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.64B | $1642.41M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.72B | $1718.2M | 100% |